Ajanta Pharma (India) Investor Sentiment

AJANTPHARM   3,027  30.05  1.00%   
Under 51% of Ajanta Pharma's investor base is interested to short. The analysis of overall sentiment of trading Ajanta Pharma Limited stock suggests that many investors are impartial at this time. Ajanta Pharma's investing sentiment shows overall attitude of investors towards Ajanta Pharma Limited.
  
few days ago at news.google.com         
Ajanta Pharma stock performs better than its underlying earnings growth over last five years - Simpl...
Google News at Macroaxis
six days ago at news.google.com         
Ajanta Pharma Ltd soars 1.25, up for fifth straight session - Business Standard
Google News at Macroaxis
over a week ago at news.google.com         
Ajanta Pharma Ltd gains for third straight session - Business Standard
Google News at Macroaxis
over a week ago at news.google.com         
Ajanta Pharma Ltd gains for third straight session - Trade Brains
Google News at Macroaxis
over three weeks ago at news.google.com         
Ajanta Pharma Limited Is About To Go Ex-Dividend, And It Pays A 1.8 percent Yield - Simply Wall St
Google News at Macroaxis
over a month ago at news.google.com         
Ajanta Pharma Limited Reports Earnings Results for the Second Quarter and Six Months Ended September...
Google News at Macroaxis
over a month ago at news.google.com         
Despite selling recently, Ajanta Pharma Limited insiders own 53 percent stake and recent decline mig...
Google News at Macroaxis
over two months ago at news.google.com         
Ajanta Pharma Limiteds Stocks On An Uptrend Are Strong Financials Guiding The Market - Simply Wall S...
Google News at Macroaxis
over two months ago at news.google.com         
Stock Radar 50 percent rally in 6 months This pharma stock gave a breakout from a bullish Flag patte...
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Limited Just Recorded A 11 percent EPS Beat Heres What Analysts Are Forecasting Next -...
Google News at Macroaxis
over three months ago at news.google.com         
Some Confidence Is Lacking In Ajanta Pharma Limiteds PE - Simply Wall St
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma extends gains for 9th day, shares surge 6 percent to hit 52-week high on 18 percent Yo...
Google News at Macroaxis
over three months ago at news.google.com         
In spite of recent selling, insiders still have the largest holding in Ajanta Pharma Limited with a ...
Google News at Macroaxis
over three months ago at news.google.com         
Ajanta Pharma Ltd Share Price Today Ajanta Pharma Ltd Stock Price Live NSEBSE, Ajanta Pharma Ltd Lat...
Google News at Macroaxis
over six months ago at news.google.com         
Ajanta Pharma buyback Last day today to buy shares for Rs 285 crore special situation opportunity - ...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ajanta Pharma that are available to investors today. That information is available publicly through Ajanta media outlets and privately through word of mouth or via Ajanta internal channels. However, regardless of the origin, that massive amount of Ajanta data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ajanta Pharma news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ajanta Pharma relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ajanta Pharma's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ajanta Pharma alpha.

Ajanta Pharma Performance against Dow Jones

 Price Growth (%)  
       Timeline  
1
Ajanta Pharma stock performs better than its underlying earnings growth over last five years - Simply Wall St
11/22/2024

Complementary Tools for Ajanta Stock analysis

When running Ajanta Pharma's price analysis, check to measure Ajanta Pharma's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ajanta Pharma is operating at the current time. Most of Ajanta Pharma's value examination focuses on studying past and present price action to predict the probability of Ajanta Pharma's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ajanta Pharma's price. Additionally, you may evaluate how the addition of Ajanta Pharma to your portfolios can decrease your overall portfolio volatility.
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Commodity Directory
Find actively traded commodities issued by global exchanges
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Idea Optimizer
Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Bonds Directory
Find actively traded corporate debentures issued by US companies